EWM
DGX icon

Evolution Wealth Management’s Quest Diagnostics DGX Stock Holding History

Evolution Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7
Closed -$1.37K – 944
2026
Q1 		$1.37K Hold
7
– – ﹤0.01% 772
2025
Q4 		$1.22K Buy
+7
New +$1.27K ﹤0.01% 675

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Evolution Wealth Management's DGX Position: Q2 2026 in Review

Evolution Wealth Management sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 7 shares — an estimated $1.37K sold.

Evolution Wealth Management first reported a position in DGX in Q4 2025 and held it in 2 quarters. The position peaked at $1.37K in Q1 2026. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Evolution Wealth Management reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Evolution Wealth Management sold 7 Quest Diagnostics shares in Q2 2026, an estimated $1.37K.
  • Evolution Wealth Management first reported a position in Quest Diagnostics in Q4 2025 and held it in 2 quarters.
  • Evolution Wealth Management's Quest Diagnostics position peaked at $1.37K in Q1 2026.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.